retatrutide type 2 diabetes phase 2 trial results 2024 weight loss Retatrutide, an experimental weight-loss drug Lilly's triple agonist, retatrutide, successful – Randomized clinical trials evaluating kidney
Pay in 4 interest-free payments of $6.84 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19


00967-0/asset/2c4cc3d7-a929-4487-9a67-b20324061067/main.assets/gr1_lrg.jpg)

00182-7/asset/aed83eb5-c537-40e6-bd67-6ea417eca1be/main.assets/gr3_lrg.jpg)




















